EMA Reviews GSK and Vir’s Monoclonal Antibody for COVID-19 Treatment
GSK and Vir Biotechnology have announced that the EMA has started a review of the dual-action monoclonal Antibody VIR-7831 for
Read moreGSK and Vir Biotechnology have announced that the EMA has started a review of the dual-action monoclonal Antibody VIR-7831 for
Read moreEvotec SE, a publicly listed drug discovery and development company headquartered in Hamburg, Germany, has launched beLAB2122, a translational $
Read moreSanofi revealed on April 12, 2021, that it will spend €400 million over five years in Singapore to build a
Read moreExscientia, a leading artificial intelligence (AI) driven pharmatech company based in Oxford, England, announced that the first AI-designed molecule for
Read moreTeva Pharmaceuticals Europe reported that Seffalair Spiromax and its duplicate BroPair Spiromax (salmeterol xinafoate/fluticasone propionate, 12.75/100 and 12.75/202 micrograms administered
Read moreThe Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), and Panacea Biotec, India’s largest vaccine and pharmaceutical manufacturer, have
Read moreContract Development and Manufacturing Organization Celonic and German biopharmaceutical company CureVac have entered into an agreement to manufacture 100 Million
Read moreJohnson & Johnson has started vaccinating teens aged 12 to 17 in the ongoing Phase 2a clinical trial for its
Read moreGSK has made an agreement in principle with Novavax and the UK Government Vaccines Taskforce to support the production of
Read moreNew data from a Phase 3 Study has shown that the investigational monoclonal antibody cocktail of casirivimab and imdevimab has
Read more